ABSTRACT
INTRODUCTION
Tenascin (TN) is a polymorphic high molecular mass extracellular matrix glycoprotein composed of six similar subunits joined together at their NF^-terminal by disulfide bonds (for reviews see references [1] [2] [3] [4] [5] .
The sequence of cDNA clones codifying for the complete chicken TN subunit has recently been reported. The deduced amino acid sequence shows that chicken TN is mainly made up of 13 and half epidermal growth factor like repeats (EGF-L), 11 units similar to fibronectin type III repeats (FN-L), and, at the C-terminal, by a sequence with 40% homology to the globular domain of the /3-and 7-chain of fibrinogen (6) (7) . It has been shown that TN displays a restricted distribution in normal adult tissues and that its expression is ontogenically programmed. In fact, TN is transiently expressed in many developing organs and it has been proposed that TN could modulate epithelialmesenchymal and neuronal-glial interactions (8) (9) (10) (11) (12) (13) . However, neoexpression, or a dramatically increased expression, of TN has been documented in a variety of tumors, thus suggesting that this glycoprotein may play a role in tumor cell-stroma interdependence (2, 8, (14) (15) (16) (17) (18) (19) (20) (21) (22) . Since it has also been shown that TN stimulates the growth of mammary tumor cells in vitro (8) , it has been advanced that TN plays a role in supporting the growth of epithelial tumors in vivo (23) .
Since transforming-growth-factor-/3 (TGF-/3) induces a dramatic increase in TN expression in cultured fibroblasts (24) , the belief has surfaced that epithelial tumor cells, which in general do not produce TN, through the release of TGF-/3 (and most likely other factors) force the surrounding mesenchymal cells to organize a tumor stroma which is different from the normal organ stroma and more suitable to sustain tumor growth and invasion (23) .
It has recently been demonstrated that TN is the same protein as miotendinous antigen (25) , JI (26) , cytotactin (12) , gliomaassociated-extracellular matrix (ECM) antigen (22) , gp 150-225
• To whom correspondence should be addressed (27) , hexabrachion (28) and neuronectin (21) all previously described.
Here we report 1) the cDNA cloning and deduced complete amino acid sequence of human TN as well as the amino-terminal sequence of the mature peptide determined directly on purified TN; 2) the splicing patterns of TN pre-mRNA in cultured cells and 3) the production of monoclonal antibodies (Mabs) to human TN as well as the localization of the epitopes recognized by these Mabs within the TN molecules using /3-galactosidase-TN fusion proteins expressed in E.coli.
MATERIALS AND METHODS

Isolation of TN cDNA clones and their sequencing
Human melanoma, human fetal brain, human melanoma SK-MEL-28 cell line and human breast cDNA libraries in bacteriophage Xgtl 1 were obtained from Clontech Laboratories (Palo Alto, CA). The first cDNA clone was obtained by screening the human melanoma library using the Mab BC-2 to human TN (15) and an immunoenzymatic kit purchased from Promega Biotec (Madison, WI). Other cDNA clones covering the complete coding region of the human TN gene were obtained by screening the above mentioned libraries with 32 P labelled DNA fragments from successively isolated TN cDNA clones. Overlapping clones spanning the entire coding region were subcloned into M13mpl9 or M13mpl8 vectors (New England Bio Labs, Beverly, MA) and analyzed in both strands using the Sequenase 2.0 DNA sequencing kit (United States Biochemical Corp., Cleveland, Ohio).
RNA extraction, cDNA synthesis, Polymerase Chain Reaction (PCR) amplification and Southern blot
Total RNA was prepared from human melanoma SK-MEL-28 cells following the method described by Chirgwin (29) . cDNA was synthetized from 10 tig of total RNA primed with oligo (dT) 12 _i8 and reverse transcribed using a cDNA synthesis kit Fig.l ), 5 U of Taq DNA polymerase (Amplitaq, Perkin Elmer Cetus, Norwalk, CT) and 0.5 ml of the cDNA mixture as template. The PCR mixture was loaded on a preparative 1.4% agarose gel; well resolved bands were cut out, electroeluted and ethanol-precipitated. The pellets were resuspended in 7 y\ of water; 2 /xl Sequenase buffer and 1 /tl (20 pmol) of sequencing primer were added. The primer/template solution was boiled for 3 min and frozen in dry ice. From this step the direct sequencing protocol follows the Sequenase manual indications. For Southern blot analysis 5 /il of the PCR mixture were loaded in two different wells of 1.4% agarose gel. Following electrophoresis, the gel was immersed twice for 15 min in 300 ml of 1.5 M NaCl, 0.5 M NaOH and twice for 15 min in 1 M NH 4 acetate and transferred for 3 hours to nitrocellulose membrane following standard techniques (30) . The filter was cut between the loaded lanes and hybridized separately with 32 (30) . The oligonucleotides were synthesized by an Applied Biosystem 370A synthesizer (Applied Biosystem, Foster City, CA).
Purification of TN and characterization of Monoclonal
Antibodies (Mabs) BC-2 and BC-4 specific to TN TN was purified from the conditioned medium of SK-MEL-28 human melanoma cell line by chromatography on hydroxyapatite (DNA-grade, Bio-Rad Laboratories, Richmond, CA) followed by immunoaffinity on Mab BC-4 conjugated to cyanogen bromide-activated-sepharose-4B (Pharmacia Fine Chemicals, Uppsala, Sweden). The complete procedure will be reported elsewhere. The purified TN was reduced and alkylated as described by Can field and Anfisen (31) . Protein sequencing was performed by the Center for Analysis and Synthesis of Macromolecules at Stony Brook (Stony Brook, NY).
cDNA libraries, in the expression vector Xgtl 1, were screened using the Mabs BC-2 and BC-4 and an immunoenzymatic kit purchased from Promega Biotec (Madison, WI). Bacteriophage DNA was prepared from positive clones, and the EcoRI inserts were excised, subcloned into a M13mpl9 vector (New England Bio Labs, Beverly, MA) and sequenced.
For immunoblotting analysis the /3-galactosidase-TN fusion protein were obtained as previously reported (32) . All the cloning and subcloning procedures were carried out according to Sambrook et al. (30) . SDS-PAGE and immunoblotting were performed as previously described (33 -34) .
RESULTS
cDNA sequence and pre-mRNA alternative splicing analysis of human TN The cDNA and the deduced amino acid sequences of human TN are shown in Fig.l . The primary structure of human TN, arranged in groups of homologous repeats as suggested for chicken TN (7), is shown in Fig.2 . The first 22 amino acids correspond to a typical signal peptide (35) (36) . Furthermore, the amino-terminal sequence of the mature peptide was determined directly on purified TN and it begins from residue 23 (Fig.2) . The domain structure of a human TN subunit is schematically represented in Fig.3 , showing the 14 and half EGF-L, the 15 FN-L and the fibrinogen like sequences and the potential N-glycosylation sites. The longer human TN reading frame is 2199 amino acids. Northern blot analysis of total RNA from the human melanoma cell line SK-MEL-28, using the insert of the clone HT-12 as probe, showed a broad band of about 6,000-7,000 bases (data not shown) as expected from our cloning data indicating the presence of several TN mRNAs in this cell line. In fact, shorter reading frames generated by alternative splicing of the TN primary transcript have also been observed.We have found a cDNA clone (HT-5) in which the FN-L repeats 6,7,8,9 and 11 were lacking and another one (HT-33) in which only the FN-L repeat 11 was lacking (Fig .4) . These observations agree and further the results by Gulcher et al. (37), who reported the sequences of two human TN cDNA clones, one containing all 15 FN-L repeats and one in which the FN-L repeats 6,7,8,9,10,11 and 12 were absent because of splicing of the TN primary transcript. In order to confirm these various splicing patterns of the human TN primary transcript, we carried out PCR amplification experiments on cDNA derived from human melanoma cell line SK-MEL-28 total RNA. PCR amplification experiments were performed using as primers the oligonucleotides Tl, hybridizing a coding region within the 5th repeat, and T5-2, hybridizing a coding region within the 12th repeat. After electrophoresis of the PCR mixture, four bands were visualized of about 1900, 1650, 550 and 280 bp respectively (Fig.4) . These bands were electroeluted and completely sequenced. Furthermore, Southern blots of the amplified fragments were hybridized with an oligonucleotide (T2) that specifically recognizes the 10th repeat, and separately with an oligonucleotide specific for the 12th repeat (T4). All four fragments hybridized to T4 as was expected due to the presence of the 12th repeat while T2 failed to recognize the smallest 284 bp fragment, confirming that it lacks the 10th FN-L repeat.
Localization within the TN molecule of the epitopes recognized by the Mabs BC-2 and BC^4 by using TN-/3-galactosidase fusion proteins expressed in E.coli In order to localize the epitopes recognized by the Mabs to human TN within the TN molecule, we have screened by an immunoenzymatic procedure, a human melanoma cDNA library in the expression vector Xgtl 1. We obtained two clones, XpTNl and XpTN27, producing /3-galactosidase-TN fusion proteins which react strongly with the Mabs BC-2 and BC-4 respectively (Fig.5) . The cDNA inserts of these two clones were purified, inserted into a M13mpl9 vector and completely sequenced. The sequencing data demonstrated that the TN part of the fusion protein produced by the clone XpTNl is made up of a sequence from the residue 1316 to the residue 1450 while the fusion protein produced by the clone \pTN27 contains the TN sequence from the residue 50 to the residue 453 ( Fig.2 and 3) .Thus, while the epitope recognized by the Mab BC-4 is present in all the TN isoforms the Mab BC-2 recognizes an epitope whose expression is regulated by alternative splicing of the TN pre-mRNA (Fig.3) .
DISCUSSION
We here report the complete primary structure of human TN deduced from cDNA clones, a study of the splicing patterns of the TN primary transcripts in cultured human melanoma cells and the characterization of two Mabs specific to human TN using /3-galactosidase-TN fusion proteins expressed in E. coli. By comparing the human and chicken TN sequences, we found two main differences: 14 1/2 instead of 13 1/2 EGF-L repeats and 15 instead of 11 FN-L repeats.
The sequence of the first 22 amino acids of human TN corresponds to that of a typical signal peptide (35 -36) .The sequence of the following 10 amino acids (residues 23-33), is strongly basic since it contains 5 positively charged residues. In chicken a homologous sequence has been considered a putative propeptide since the mature chicken peptide started at residue 34 (6) . However, direct amino-terminal sequencing of purified human TN shows that the mature peptide starts at residue 23 thus including this positively charged sequence that in chicken has been reported not to be present in the mature peptide. This discrepancy may be explained by the fact that the chicken TN used to determine the amino-terminal sequence was purified from tissues (insoluble TN) (6) while we have purified TN from the medium of cultured cells (soluble TN).The removal of this very basic sequence might be a crucial step in the process of TN assembly in the extracellular matrix.We are currently conducting experiments to confirm this possibility. As in the case of chicken TN a secondary structure prediction of the sequence from residue 119-147 shows a high probability to form a-helix. Thus, the primary structure of human TN is compatible with the model of the TN hexamer suggested by Spring et al. (7) . About 2/3 of the primary structure, deduced from the sequence of cDNA clones, have already been reported by Gulcher et al. (37) , more specifically from base 1342 to base 6217 of our sequence reported in Fig. 1 . With respect to this sequence we found only few differences (see Legend of Fig. 1 ) with the exception of residues 1599-1607 where we have the following sequence: SGFTQGHQT while in (37) LWLHPRASN (residue 1170 to 1178 of their sequence) has been reported. This difference is due to the fact that we found CT at bases 4848 -4849 instead of CCT thus, this single base insertion introduces a frameshift. Furthermore, we found CCA at bases 4875-77 instead of CA reestablishing the frame of the TN sequence previously reported (37) . Since the double C reported by Gulcher et al. (37) at bases 4848-4849 should generate a cleaving site for the restriction enzyme Ava II we have tested an appropriate cDNA clone with this enzyme. The absence of this cleaving site confirms our sequence.
In chicken TN there are three FN-L repeats that undergo alternative splicing which generates three different TN subunit isoforms (6-7). It has been reported that in human TN seven FN-L repeats undergo alternative splicing since two different cDNA clones, one with all these seven FN-L repeats and the other one in which all seven were missing, have been isolated (37) . From the cDNA libraries tested we have found many cDNA clones covering the human TN area which were obviously derived from alternative splicing of pre-mRNA. However, the smallest clone we found contains two repeats of the seven which undergo alternative splicing (repeats 10 and 12).We also found a clone in which only repeat 11 was missing and clones in which all the seven repeats were present. We did not find any clones in which all the seven repeats were missing. We have also studied, by PCR amplification on cDNA obtained from total RNA from the melanoma cell line SK-MEL-28, the possible different splicing patterns of the TN primary transcript. As reported in 'Results' we observed 4 different bands, one containing all the seven repeats, one only repeats 10 and 12, one containing only repeat 12 and one in which only repeat 11 was missing. However, the above reported results do not give any quantitative estimation on the relative abundance of the different isoforms of TN since the efficiency of amplification of the various cDNA species may be different. We are currently studying the relative abundance of TN isoforms in different tissues by RNAase protection analysis.
By homology comparison between the seven FN-like repeats involved in alternative splicing in human and three FN-L repeats involved in alternative splicing in chicken, it has been reported that human repeats 6,7,8,9 have an extremely high homology with repeat 6 in chicken, thus supporting a recent reduplication of this sequence (38) . In fact, our results have shown that human repeats 6 to 9 (which should correspond to the chicken repeat 6) have up till now been observed to always be included or excised as a block. Furthermore, there is a high homology of chicken FN-Like repeat 7 to human FN-L repeat 10, and a high homology of the chicken FN-L repeat 8 to human FN-L repeat 12. However, there are no chicken repeats with high homology to the human FN-L repeat 11. Considering that the cDNA clones containing repeat 11 are the rarest, in our study at least, a chicken FN-L repeat corresponding to the human FN-L repeat 11 might have escaped previous analysis (6-7). Furthermore, repeat 11 has been, up till now, found only in cDNA clones containing all other repeats undergoing alternative splicing and only in a fetal brain cDNA library. These data indicate that the splicing patterns of human TN are quite complex and require further investigation.
At present possible biological functions of different TN isoforms may only be a matter of speculation. However, it is worth noting the high concentration of potential N-glycosylation sites in the repeats which may undergo alternative splicing. Furthermore, Prieto et al. (39) reported spatio-temporal changes during chicken development of two forms of TN mRNA. We are presently approaching the study of the biological functions of different TN isoforms by 1) preparing Mabs able to recognize different TN isoforms in order to perform a detailed analysis of the distribution of various TN in different tissues and in different physiological conditions and 2) establishing procedures for the production and/or purification of different TN isoforms.
